B-cell Lymphoid Cancer

1 clinical trials · Condition

Record	Firm	Date
A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy Subjects (NCT04488016)	AstraZeneca	2020-06-24

Every clearance here is in the API, with alerts when new ones post.